We have studied the peripheral T cell repertoire of two patients with severe combined immunodeficiency who were successfully treated with human histocompatibility leukocyte antigen (HLA)-mismatched fetal liver stem cell transplantation. The patients presented a split chimerism. T cells were of donor origin, whereas the B cells / monocytes were of the host phenotype. Interestingly, the natural killer (NK) cells in one patient were donor derived and in the other patient of host origin. The NK cells were functional but did not have antihost or donor reactivity.
Introduction
Severe combined immunodeficiency (SCID)' encompasses a variety of congenital disorders characterized by abnormal lymphoid development. Although different genetic defects can be responsible for the disease, infants with SCID share a profound impairment of both cellular and humoral immune functions ( 1, 2) . Bone marrow transplantation (BMT) from an histocompatible donor is the treatment of choice for these patients (2, 3) . However, when HLA-identical donors are not available, transplantation with mismatched fetal liver stem cells, obtained from first trimester donors, has been shown to be successful (4) . During the first trimester ofgestation, the fetal liver is the major source of stem cells and is virtually free of mature T cells capable of provoking a graft-versus-host disease (GVHD). In addition, SCID patients are naturally devoid of functional T cells able to reject the transplant and therefore they do not require immunosuppressive conditioning therapy. However, in the absence of initial myeloablation, engraftment is generally confined to the T cell compartment, especially when host B cells are present prior to the transplant. Despite this split chimerism, these subjects develop normal immunological functions including normal in vivo and in vitro antibodies responses (5, 6) .
SCID chimeras represent one of the few examples of successful stem cell transplantation across HLA-mismatched barriers and therefore may serve as a model system to investigate the mechanisms of induction and maintenance of tolerance following allogeneic transplantation. The understanding ofthe underlying mechanisms may be useful, not only for allogeneic transplantation in immunodeficiencies, but also for transplanting patients suffering from lymphopoietic malignancies who lack histocompatible donors. Thus far, little is known about the extent ofchimerism, the development ofdonor T cell repertoire and the mechanisms of tolerance in patients reconstituted with mismatched stem cells (4, (7) (8) (9) (10) .
In this article, we analyze the peripheral T cell repertoire of two SCID children reconstituted with fetal liver transplantation (FLT). In addition, we characterize the chimeric state of these two patients and we determine the frequencies of host and donor-reactive cells. It is shown that both patients, who are in good health, have T cell receptor (TCR) afl' and TCRy6 + T cells ofdonor origin, whereas B cells and monocytes are of host origin. Interestingly, the extent of the chimerism varied. In one patient the natural killer (NK) cells express the HLA phenotype of the host, whereas in the other they are of donor origin.
Furthermore, it is demonstrated that donor derived TCRaf3'-CD4 + and CD8 + host-reactive T cell clones could be isolated from both patients at high frequencies ( 1 1). However, these T cells were unresponsive toward the host HLA antigens in a 1. Abbreviations used in this paper: BMT, bone marrow transplantation; EBV-LCL, Epstein-Barr virus-transformed lymphoblastoid B cell primary mixed leukocyte culture (MLC), suggesting that a peripheral regulatory mechanism ofsuppression or anergy, rather than clonal deletion, is involved in maintaining tolerance in these patients.
Methods
Clinical history andfollow-up. Patient R.V. is 5 yr old. He was born with a normal weight after an uncomplicated pregnancy. He had no family history of SCID. He became severely ill at 8 mo of age with recurrent fever and suffered from intestinal and respiratory tract infections unresponsive to therapy. The delayed hypersensitivity skin test to tetanus toxoid (to which he had been vaccinated) was negative. The thymic shadow and pharyngeal lymphatic tissues were undetectable on X-rays. Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency activity were within the normal range. In a 2-mo period the WBC markedly decreased, especially in the number oflymphocytes (from 2,800 to 800/mm3). The phenotype of the patient's PBMC showed profound decrease in the CD2', CD3', CD4', and CD8+ T cells (< 6%), whereas a relatively high percentage of B cells was present (Table I ). The proliferative responses to mitogens were also strongly impaired. Serum IgG and IgA levels were far below the normal range and IgM levels were at the lowest levels of normality.
Specific antibodies were undetectable.
Based on these clinical manifestations and biological findings, the diagnosis of SCID with absence of mature T cells and presence of non functional B cells was made. The child was isolated in a sterile room and, because no HLA identical donor was available, he received fetal hematopoietic stem cell transplantations. Seven transplants from as many unrelated donors were given over a 6-mo period (from June to December 1987). In each case, a cell suspension of liver tissue, obtained from fetuses ofgestational age ranging between 7 and 12 wk, was injected intravenously; in four cases, the autologous thymus was simul- The T cell lines were obtained from patients' PBMC and parents' PBMC after PHA (0.1 g/ml) stimulation in the presence of IL-2 (20 U/ml). The T cell line of host origin (Blast 87) was obtained from pretransplant RV-PBMC which have been activated with PHA. These cells were stimulated twice with feeder cell mixture consisting of 5 X 105/ml PBMC (irradiated at 4,000 rad), 5 X 14OJY EBV-LCL (irradiated at 5,000 rad), and PHA and expanded in the presence of IL-2, IL-4 (200 U/ml), and IL-7 (10 ng/ml). All T cell lines were weekly restimulated with the feeder cell mixture and maintained in culture with IL-2.
HLA typing. HLA typing of both patients was carried out on purified T and B cells, T cell clones, EBV-LCL, and NK clones using a cytotoxicity assay previously described (13) . HLA-DR was further determined on purified T cells, B cells, and monocytes by polymerase chain reaction (PCR)/oligotyping as described (13 noted. CDl la (anti-LFA-la), CD18 (anti-LFA-Ifl), CD28 (anti-CD28, L293), CD29 (anti-VLAf), and CD49 (anti-VLAa4) mAbs were kindly provided by L. Lanier (DNAX Research Institute). Hybridoma's producing mAbs against allotypic HLA determinants MA2.1 (anti-HLA-A2) and SFR3-DR5 (HLA-DR5), which recognize both HLA-DR1 1 and HLA-DR12 subtypes, were obtained from the American Type Culture Collection (Rockville, MD).
Fluorescence analysis. For detection of cell surface antigens, 105 cells were labeled with mAbs and FHTC-labeled goat anti-mouse antibodies or with FITC or phycoerythrin conjugated mAbs. The cells were incubated for 30 min with the appropriate mAb in PBS with 0.1 % BSA and NaN3 in all staining experiments as described (11) .
To detect the cytoplasmic CD3 proteins, cells were fixed in PBS containing 0.1 % paraformaldehyde at 4°C overnight. After two washes, cell membranes were permeabilized by treatment with PBS containing 0.1 % Triton X-100 on ice for 30 min and then stained.
Proliferation and cytotoxic assays. The proliferative response ofthe patients' PBMC towards the HLA Ags ofthe host was tested in a MLC by stimulating 2 X I05 PBMC with 2 x 104 irradiated host EBV-LCL or HLA-matched monocytes in round-bottomed 96-well plates. After determined by scintillation spectroscopy. Proliferative responses of host-reactive T cell clones were tested as previously described (11) .
Cytotoxic activity of NK cells and T cell clones was measured in a standard 4 h 5'Cr-radioisotope release assay (11) . K562 (erythroleukemia), Daudi (Burkitt lymphomas), and JY (EBV-LCL) were used as NK-sensitive targets.
Determination oflymphokine production. To evaluate lymphokine production, resting host-reactive T cell clones collected 8-10 d after stimulation with the feeder cell mixture, were washed and stimulated with the host's EBV-LCL or with 10 ug/ml ofConA at 106 cells/ml, as described (17). After 22 h of incubation the supernatants were harvested and tested. The presence of IL-2, IFN-,y, IL-4, IL-5 and GM-CSF was quantified by immunoenzymetric assays performed as previously described (17, 18). Sensitivity of each assay was 20 pg/ml for IL-2, IL-5 and GM-CSF; 40 pg/ml for IL4; 100 pg/ml for IFN-,y.
Limiting dilution analysisfor lymphokine secreting and cytotoxic T cells. The frequency analysis was performed as previously described (19). Briefly, CD8 + T cells, obtained by cell sorting on a FACStar Plus, from PHA-activated PBMC ofpatient R.V. and freshly isolated PBMC of patient S.P., were seeded manually at 0 (for background determination), 1 (for determination of cloning efficiency), 10, and 20 cells per well in 96-well round-bottomed plates, with feeder cell mixture. After 1 wk, fresh medium and IL-2 were added. After an additional 5 d the cultures were washed, split, and tested against different targets for determination of cytotoxic cells frequencies. To determine IL-2-secreting cells, the cultures were incubated for an additional week. Subsequently, they were stimulated with different EBV-LCL. The supernatants were harvested after 20 h and IL-2 activity was assayed in duplicate on the mouse cell line CTLL-2 as described (18) .
Results
HLA typing and detection of chimerism. In order to confirm engraftment and to evaluate the extent of chimerism, HLA typing of patients' PBMC was performed at different times after the transplantations. The HLA typing of the patients and the engrafted donors is shown in Table II . In patient R.V., the presence of only one population of cells with an allogeneic HLA phenotype was detected by serology and PCR analysis carried out on PBMC, indicating that only one of the seven unrelated transplants was engrafted. HLA typing of the fetal material before the transplantations was not performed, therefore it is not known which transplant has led to the successful engraftment. The donor and host cells shared one ofthe HLA-A and -C alleles (HLA-A2; Cw4), but they were mismatched for the other HLA alleles.
HLA typing of the PBMC of patient S.P., who received FLT from two different donors, revealed stable engraftment of cells from the second donor (10; Table II ). In addition, 10-20% of the circulating T cells were derived from the first transplant. The HLA phenotypes of both donors were completely mismatched with those of the host.
Standard HLA typing carried out on purified TCRafl+ and TCRy6y T cells, B cells, NK cells, and freshly isolated monocytes showed that in both patients the T cells were exclusively of donor origin. In patient S.P., TcRaf3' and yb' T cells derived from both the first and the second donor were detectable. In contrast, B cells and monocytes, which were already present before the transplants, remained ofhost origin (Table II) . Interestingly, the NK cells in the patients were of different origin. The NK cells in patient R.V. were of donor origin, whereas in S.P. they were of host origin. The chimerism was confirmed in both patients by phenotyping > 100 TcRaflc T cell clones, 30 TcR6y + T cell clones, EBV-LCL, and NK cell clones ( 108 NK clones from patient R.V., 85 NK clones from S.P.). An example of this phenotyping is shown in Fig. 2 . An anti-HLA-DR5 mAb, which recognizes both HLA-DR 1I and HLA-DR 12 subtypes, was used to detect cells of donor origin in patient R.V. and an anti-HLA-A2 mAb was used to identify donor derived cells in patient S.P. All TCRafl' and -y3' T cell clones, isolated from both patients, were of donor origin (HLA-DR5 + in R.V. and HLA-A2+ in S.P.). TCRaf3+ T cell clones included TTspecific T cell clones (20) , host-reactive (see below) and alloreactive T cell clones (21 ). EBV-LCL failed to stain with HLA-DR5 or HLA-A2 specific mAbs, indicating that they were of host origin. RV-NK cell clones were of donor origin (HLA-DR5+), whereas SP-NK cell clones were all host derived (HLA-A2-). Characterization ofNK cells. The NK cells of patient R.V. appeared in the peripheral blood late after reconstitution. HLA typing revealed that they derived from the fetal donor. To determine their differentiation stage, we studied the expression of different markers such as CD16, CD57, Leu8, and intracytoplasmic CD3 (cCD3), which distinguish adult NK cells from immature NK cells (22) (23) (24) (25) . Similarly to immature NK cells, freshly isolated NK cells from patient R.V. expressed low amounts ofCD16 (Fig. 1 ) and CD57 (not shown), whereas the majority of the NK cells present in the peripheral blood of normal donors have high expression of both markers (25) . RV-NK cell line J201 was CD2 , CD3 -, CD56 bright, weakly expressed the CD16 marker and was negative for CD57 and Leu8 (Fig. 3) . Furthermore, CD 16 expression on RV-NK cell clones varied from negative to weakly positive. However, in contrast to immature NK cells, no cCD3e and chains could be detected in the RV-NK cell line (Fig. 3) and RV-NK cell clones (not shown). The phenotype of host derived NK cells of patient SP was comparable to that ofadult NK cells (25) . Freshly isolated SP-NK cells expressed high levels ofCD16 and CD57. SP-NK cell lines and SP-NK cell clones were CD2 +-CD3 cCD3-CD56+CD57-Leu8-and had high expression of CD 16 (not shown).
The cytotoxic activity of NK cell clones isolated from both patients is shown in Fig. 4 (27) . The addition of different concentrations of anti-CD28 mAb did not reverse the unresponsiveness of the PBMC ofpatient SP towards the host cells (Table IV) addition, various concentrations of exogenous IL-2, which has been shown to break tolerance in many models (26, 28, 29), failed to restore specific responsiveness in the primary MLC, despite the fact that considerable levels ofnon specific proliferation were induced (Table IV) . Similarly, IL-4, which has T cell growth promoting activity (30), had no effects.
Isolation and characterization ofhost-reactive T cell clones. We previously reported that CD4' and CD8+ T cell clones specific for the HLA determinants of the host could be isolated from PBMC of patient S.P., after stimulation with host EBV-LCL, despite the in vivo tolerance and the in vitro unresponsiveness to the mismatched cells of the host ( 11) . Comparable host-reactive T cell clones were obtained after polyclonal activation of the PBMC with PHA (21 ). Host-reactive T cells are also present in the PBMC of patient R.V. Host-reactive T cell clones were obtained both after polyclonal stimulation of the PBMC with aCD2 mAbs and after activation with the host EBV-LCL (UD1 53) in the presence of IL-2. All clones were TcRafBCD2+CD3+. They expressed normal levels of CDl la/CD 18 and CD49/CD29. The fluorescence intensity of CD28 expression was similar to that of control alloreactive T cell clones (obtained from the patients and from normal donors) and varied from dim to bright. Proliferative responses, cytotoxic activity and IFN-y production of 20 representative T cell clones out of 56 host-reactive T cell clones obtained from patient R.V. are shown in Table V . The CD4+ T cell clones proliferated in response to the EBV-LCL UD1 53 ofhost origin, whereas they did not respond to allogeneic EBV-LCL which did not share any relevant HLA Ags with the host (not shown). For some of the CD4+ T cell clones the proliferative responses to UD1 53 were persistently low, however the IFN-y production, which was tested simultaneously, was high. The CD8 + T cell clones were highly cytotoxic against UD1 53 and against the host PHA-activated T cell blasts and they produced variable amounts ofIFN-,y when stimulated by the host cells. Proliferative responses of the CD4+ and cytotoxic activities of the CD8 + host-reactive T cell clones of patient R.V. were specifically blocked in the presence of anti-HLA class II and class I mAbs, respectively (not shown).
To further study the specificity of these clones, their ability to recognize the parental cells was tested. In Table VI it is shown that some of the CD8 + host-reactive clones (A24, B44, 2/3, 2/7, and 2/ 13) were specifically cytotoxic for the T cell blasts of the father, sharing the HLA-A3 1, Cw4, B62 with the host, and not for the cells ofthe mother. The other clones were cytotoxic against the mother's PHA-activated T cell blasts, that share HLA-A2, Cw7, B37 with the patient. In addition, none of the clones tested were cytotoxic against the T cell blasts of the donor. In particular, no T cell clones specific for HLA-A2 antigen, shared by donor and host, could be identified. This suggests that host-reactivity is directed only against the HLA Ags of the host which are not present on the donor cells.
Lymphokineproduction profile. The pattern oflymphokine production by CD4+ and CD8+ host-reactive T cell clones of patient RV, after ConA activation, is shown in Table VII. As previously described for T cell clones obtained from normal donors ( 31 ), both subsets of host-reactive T cell clones produced high amounts of IFN--y and synthesize granulocyte/macrophage colony-stimulating factor (GM-CSF), IL-2, and IL-5. In contrast, both CD4+ and CD8+ host-reactive T cell clones were unable to produce IL-4, whereas the majority of T cell clones isolated from normal donors synthesize IL-4 (31 ) . The lack of IL-4 production by host-reactive T cell clones was confirmed at transcriptional level by PCR (not shown).
Frequency analysis ofCD8+ host-reactive Tcells. 
Discussion
We have studied the chimerism and the development of donor T cell repertoire in two SCID patients reconstituted with HLAmismatched allogeneic fetal liver stem cell transplantations. Both patients suffered from SCID with a selective T cell defect and normal numbers of B cells and were transplanted during the first year of life. They received multiple transplants, from different unrelated donors, and in many cases the fetal liver cells were injected together with a cell suspension obtained from the autologous thymus. These conditions increase the probability of engraftment, since they allow the injection of a high number ofcells which may find proper support for growth In patient R.V., as in other patients, the time frame of reconstitution was relatively slow. A stable normalization of the percentages of peripheral mature T cell subsets was detected four months after the first transplant. This could be due to the injection of cell suspensions containing only highly immature cells or to a greater difficulty of allogeneic stem cells to differentiate in a mismatched environment. In line with these explanations is the observation that the time required for the appearance of functional lymphoid cells is much longer after T cell depleted haploidentical bone marrow stem cells than after unfractionated HLA-identical marrow cell transplantation (7) . A persistent inverted CD4+/CD8+ ratio is a common finding after FLT, whereas after BMT the appearance of CD8+ cells precedes that of CD4' cells only during the early phase of reconstitution and the CD4+/CD8+ ratio rapidly becomes normal (7, 34) . A high percentage of TCRyby+ cells was observed in the peripheral blood of patient R.V. 3 yr after transplantation. They represented 40% of the CD3+ cells and they de- ( 12, 35, 36) . The V6 1 subset is predominant in the thymus and in cord blood, whereas the proportion of the V62+ subset progressively increases in the peripheral blood after birth. In children and adults > 70% of the TCR'yb+ T cells present in the peripheral blood are V62'. The V62' TCRyb' T cells have high expression of the memory cell marker CD45RO, whereas the V6 I' cells are CD45RA . The V62 + cells appear to represent an Ag responding population of TCRyb + T cells and it has been demonstrated that their expansion results from nongenetic environmental stimulation by antigens such as mycobacteria ( 12, 36) . Interestingly, in patient R.V. all TCRy6' T cells were V62+CD45RO', suggesting that they represent a subset of in vivo activated cells which may have undergone abnormal expansion. High percentages of TCR-yb+ T cells have also been observed in SCID patients reconstituted after HLA-mismatched T cell-depleted BMT (37) . However, these TCRy6+ T cells of BMT patients were V6 1, which may reflect a lack of maturation (37) . Furthermore, these TCRyb + cells have been implicated in antidonor reactivity (38) . In our case it can be ruled out that lyb-bearing cells are involved in antihost or antidonor reactivity ( 33, 38 ), because none of the TCR~y6 + T cell clones tested had any activity against the donor or the host cells.
In both patients, all af and zy T cells were of donor origin, whereas B cells and monocytes, which were present before the transplants, remained of host origin. The mismatch between the T cell and B cell / monocyte populations may be responsible for the fact that the ability to produce immunoglobulins usually takes a long time to develop (3, 8) . However, normal antibody responses can eventually be obtained in vivo and in vitro (4, 6) . It is interesting to notice that the engraftment of only T cells, and not of B cells, is a common feature in SCID patients who have a selective defect in T lymphocyte differentiation/function, but have phenotypically and functionally normal B cells prior to the transplant. This may reflect an advantage in growth and differentiation of the donor cell population, which is originally defective in the recipient. Self-reactivity of the donor T cells against the donor B cells has also been implicated in preventing donor B cell engraftment (39) (40) (41) , but this mechanism can be excluded in our patients, since donor versus donor reactivity was not observed.
In contrast to monocytes and B cells, the CD3 -CD56 + NK cell populations were ofdifferent origin. In patient S.P., all NK cells were host derived, whereas in patient R.V. they were of donor origin and no NK cells of host origin were detectable prior to, or after transplantation. These findings may imply heterogeneity in the defects affecting the two SCID patients. In the case where the NK cells were of donor origin, it could be due to a defective common progenitor of T and NK cells, whereas in patient S.P., in which NK cells were of host origin, the T cell defect could have occurred at later stages of differentiation. This hypothesis is supported by a previous study in which a clear heterogeneity in the NK cell function among SCID patients was demonstrated (42) . The role of the NK cells in preventing engraftment of allogenic transplantation is still controversial (3, 7, 8, 43, 44) . It has been reported that recipient NK cells may inhibit engraftment of allogenic transplantations in mouse and human (43, RV T cell blasts and SP EBV-LCL were used as targets. § Donor-derived T cell clones and T cell blasts were used as targets. 44 ). Furthermore, it has been suggested that donor NK cells may be involved in the development ofGVHD (45) . However, no clear correlation between the presence of NK activity and graft failure has been observed in SCID patients transplanted with haploidentical marrow stem cells (7) . Similarly, in our patients host or donor derived NK cells did not prevent the stable engraftment of donor T cells and the establishment of tolerance.
Engraftment of donor NK cells has already been described in marrow grafted animals, in patients undergoing allogeneic marrow transplantation for hematologic malignancies, and in SCID patients transplanted with haploidentical T cell-depleted bone marrow stem cells (7, 8, 46, 47) . However, it is not clear whether the presence ofdonor NK cells in the host is the result of differentiation from bone marrow precursors or is due to survival of mature NK cells present in the bone marrow cell suspension. The presence of donor origin NK cells in patient RV, appearing late after reconstitution, suggests that they derive from NK precursors present in the fetal liver. Previous studies have demonstrated that the majority ofperipheral adult NK cells have high CD16 and CD57 expression, whereas a small subset of peripheral adult NK cells (< 1%) (22) and all NK cells derived from fetal liver are weakly positive or negative for CD16 and are negative for CD57 (23, 25) . Both (22, 23) . Functional analysis demonstrated that both host and donor derived NK cells had very high killing capacity although they were not cytotoxic for donor and host cells.
Despite the split chimerism and the presence ofNK cells, in both patients complete tolerance was achieved and no sign of GVHD has been observed. This tolerance has also been demonstrated in vitro by the unresponsiveness of fresh PBMC to the HLA Ags of the host in a primary MLC. Mixing experiments showed that this unresponsiveness to the host was not due to suppression (Roncarolo et al., unpublished data) . The lack of responsiveness of donor-derived cells to the host cells in a primary MLC occured also in chimeric patients reconstituted with haploidentical bone marrow cells (39, 48, 49) .
These observations, together with the notion that cellular cooperation between donor T cells and host cells occurred in vivo and in vitro (4, 6) , suggest that donor stem cells underwent education in the host thymus. In favor of this hypothesis is the observation that in patient R.V. the thymic shadow became detectable by X-ray after transplantation. However, hostreactive T cell clones could be isolated from the PBMC of patient S.P. indicating that host-reactive T cells are not deleted from the donor T cell repertoire ( 1 1). This finding is extended here to patient R.V. CD4+ and CD8+ T cell clones specific for the HLA determinants expressed by the host were isolated after polyclonal or antigen stimulation, in presence of IL-2. All CD8 + T cell clones were strongly cytotoxic to the host cells and were specific for class I HLA determinants. The CD4+ T cell clones were mainly proliferative and recognized class II HLA antigens.
The pattern of lymphokine production by the host-reactive T cell clones of patient R.V. was quite unique and comparable to that previously described for the host-reactive T cell clones isolated from patient S.P. ( 19). In both patients the host-reactive T cell clones were unable to produce IL-4, whereas they produced GM-CSF, IL-2, IFN-y, and IL-5 and therefore they do not fit the TH 1-like or TH2-like helper cell compartments.
Whether this lack of IL-4 production contributes to the fact that these cells are non functional in vivo, remains to be clarified.
The frequencies of CD8 + host-reactive cells in patient S.P. were comparable to frequencies of alloreactive cells, whereas the frequencies of cells reactive against the first donor were comparable to the autoreactivity observed in normal donors ( 19). In patient R.V. the frequencies of CD8+ host-reactive cells were high, but lower than those against alloantigens. Overall, these findings exclude the possibility that the unresponsiveness observed in both patients in the primary MLC was due to a low frequency of host-reactive cells.
Interestingly, no donor reactivity could be detected. In patient R.V., no reactivity against the HLA-A2 antigen shared between the host and the donor was observed among all the CD8 + T cell clones tested. In patient S.P., we could not find T cell clones specific for HLA antigens of the first or second donor even after in vitro activation of the PBMC with EBV-LCL isolated from the first donor (Roncarolo et al., unpublished data). This lack of donor reactivity contrasts with results obtained in SCID patients transplanted with HLA haploidentical bone marrow (38) (39) (40) (41) 49) . The discrepancy between our data and those reported in these studies may be related to intrinsic differences between differentiation of fetal liver stem cells and bone marrow stem cells. These differences may also be due to the use of T cell clones versus PBMC or T cell lines (38) . In addition, in the study where donor-reactive T cell clones could be isolated, they were CD4+ and class II MHC specific, which is in line with the observation that class II MHC specific autoreactive clones can also be isolated from normal donors (50) . On the other hand, we could not exclude that the presence ofdonor derived thymic stroma cells played a role in preventing antidonor reactivity. However, the notion that no Ag specific T cells restricted by the donor HLA could be detected argues against this hypothesis (20) . In addition, as discussed below, human thymic epithelium does not induce negative selection.
Collectively, our data show that after reconstitution with allogenic fetal liver stem cells' tolerance toward both host and donor can be achieved. However, host-reactive cells are not deleted from the T cell repertoire of the patients, whereas donor-reactive cells are absent. This suggests that the donor cells, during their differentiation in the host environment, underwent negative selection to the donor, but not to the host HLA determinants. This can be explained by assuming that the host thymus, in which the donor T cell precursors differentiated, contained functional thymic epithelium, but no dendritic cells, macrophages or B cells of the host. In contrast, hematopoietic cells of donor origin, although progressively disappearing from the periphery (4) , could still be present in the host thymus. This hypothesis is supported by our recent studies in SCID-hu mice transplanted with fetal liver and fetal thymus from the same or from different, HLA mismatched, donors in whom hematopoietic cells offetal liver origin differentiate in an allogeneic thymus. Histological analysis ofthe structure ofthe "host" thymus in these SCID-hu mice showed the presence of dendritic cells, macrophages and B cells which are exclusively of fetal liver donor origin, whereas the thymic epithelium was derived from the fetal thymus donor. T cells which mature in this "chimeric thymus" acquire tolerance to both donor and host, but via different mechanisms. In the SCID-hu thymus, hematopoietic cells of the donor induce tolerance to the antigens expressed on their membrane by clonal deletion, whereas thymic epithelial cells ofthe host mediate tolerance by non-deletional mechanisms, probably involving clonal anergy ( 19).
The mechanisms underlying the unresponsiveness of the donor derived T cells to the host in the MLC remain to be determined. It has been demonstrated that the stimulation via the TCR in the absence of a costimulatory signal, such as provided by CD28/B7 interaction, induces a state of T cell unresponsiveness which may be an important mechanism for the establishment of peripheral tolerance in vivo (26, 27) . This unresponsiveness can be restored by the addition ofanti-CD28 mAb (27) . In our study, addition of anti-CD28 mAb to the primary MLC did not break the unresponsiveness of the patient's PBMC to the host cells, suggesting that the lack of CD28 /B7 interaction is probably not involved in maintaining in vivo tolerance. Furthermore, exogenous IL-2, which has been shown to break T cell tolerance in many models (26, 28, 29) was ineffective in restoring specific proliferation in the primary MLC of S.P. In addition, IL-4 which has T cell growthpromoting activity (30) had no effect. However, the fact that the majority ofthe CD4+ host-reactive T cell clones had low, or no detectable proliferative capacity in response to the relevant alloantigens may reflect some degree of dysfunction of these cells.
In conclusion, in SCID patients transplanted with allogeneic fetal liver stem cells, the donor precursor cells can mature in the allogenic environment and give rise to a complete immunoreconstitution of the host. Despite the heterogeneity of the chimerism that is established, complete tolerance is achieved between the HLA mismatched donor and host cells. However, this in vivo tolerance is not due to clonal deletion of host-reactive cells from the peripheral T cell repertoire of the patients, but rather to an autoregulatory mechanism of suppression or clonal anergy.
